Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsCash from RestructuringChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LENZ Therapeutics (LENZ) Change in Accured Expenses (2022 - 2025)

LENZ Therapeutics (LENZ) has disclosed Change in Accured Expenses for 4 consecutive years, with $5.0 million as the latest value for Q4 2025.

  • Quarterly Change in Accured Expenses rose 287.44% to $5.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $11.0 million through Dec 2025, up 247.12% year-over-year, with the annual reading at $11.0 million for FY2025, 247.12% up from the prior year.
  • Change in Accured Expenses for Q4 2025 was $5.0 million at LENZ Therapeutics, up from $4.5 million in the prior quarter.
  • The five-year high for Change in Accured Expenses was $5.0 million in Q4 2025, with the low at -$7.2 million in Q1 2024.
  • Average Change in Accured Expenses over 4 years is $344384.6, with a median of $721000.0 recorded in 2024.
  • The sharpest move saw Change in Accured Expenses plummeted 4782.43% in 2024, then soared 518.45% in 2025.
  • Over 4 years, Change in Accured Expenses stood at $453000.0 in 2022, then crashed by 132.67% to -$148000.0 in 2023, then soared by 977.03% to $1.3 million in 2024, then skyrocketed by 287.44% to $5.0 million in 2025.
  • According to Business Quant data, Change in Accured Expenses over the past three periods came in at $5.0 million, $4.5 million, and $2.7 million for Q4 2025, Q3 2025, and Q2 2025 respectively.